STAT+: Five burning questions on Trump’s latest deals with drugmakers

The Trump administration has announced that a second group of pharmaceutical companies has pledged to lower drug prices to levels comparable to those in other nations. According to The Hill, President Trump said every drug will be at the lowest prices available anywhere in the world.

Quartz reports that the new agreements bring the total number of companies in the administration's most-favored-nation pricing program to 26. The Hill and Endpoints News both state that nine midsize biotechnology and pharmaceutical companies are involved in the new agreements.

The details of the deals are not public, and some questions remain unanswered, including whether all the companies will avoid tariffs or mandatory Medicare drug pricing pilot programs, as reported by STAT News.

Brief written by urgent.news from STAT News, Quartz, The Hill, Endpoints News — 4 reports on this story. Machine-written — may contain errors; check the original before relying on it.